Cell therapy for kidney injury: different options and mechanisms--mesenchymal and amniotic fluid stem cells.


BACKGROUND Acute kidney injury (AKI) is emerging as a public health problem in developing and developed countries. It affects up to 7% of hospitalized patients, with a higher prevalence in critical care units. Despite major advances in preventive strategies and support measures, the mortality rate among patients remains higher than 50%. Several… (More)
DOI: 10.1159/000360667


1 Figure or Table

Slides referencing similar topics